SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Oct 15
 -2.13 / -1.68%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").


1 month-1.52% 3 years+13.95%
3 months+0.87% 5 years+16.58%
1 year+6.24% Since inception+14.22%
Data through 10/15/2021

Quote Details

Previous close$127.10
Open day’s range124.81 – 128.23
Net asset value (NAV)127.10 (10/14/2021)
Daily volume4,530,575
Average volume (3 months)4,883,348
Data as of 5:08pm ET, 10/15/2021

Peer Comparisonvs. Health ETFs

Performance 5-yr return+16.58%+13.75%
Expense Gross exp ratio0.35%1.01%
Risk 5 year sharpe ratio0.560.74
Net assets$7.2B$2.4B
Average market cap$2.8B$34.7B
Average P/E--25.1
Dividend / Share--0.29%


IEHS iShares Evolved U.S. Healthcare Staples ...
RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
XLRN Acceleron Pharma Inc0.99%
CYTK Cytokinetics Inc0.92%
SRPT Sarepta Therapeutics Inc0.87%
SGEN Seagen Inc0.85%
TGTX TG Therapeutics Inc0.85%
MCRB Seres Therapeutics Inc0.84%
CCXI ChemoCentryx Inc0.84%
DVAX Dynavax Technologies Corp0.83%
IOVA Iovance Biotherapeutics Inc0.82%
IRWD Ironwood Pharmaceuticals Inc0.81%